SIGN UP LOGIN    
STEMON Inc.
Country Korea, South
Tel +82-31-622-7720
URL stemon.co.kr/ko/

EXHIBITION    CI KOREA 2024

Booth No. 7A103
last updated on ( 2024-04-19 )

/STEMON Inc. is a specialized cell reprogramming popularization-leading company, opening up a new future using this game changer’s technology. Our mission is to chase a new health for good health and to be a leader in autologous cell therapy with Entr-based automation system. STEMON Inc. was established in March 2018, and based on our original technologies for cell reprogramming (Entr® technology) and mass production of exosome (Reprosome®) with selective specific factor (cell reprogramming factor) it has developed and produced extracellular vesicles-based therapeutics, medical devices, and dermal and hair care product. STEMON Inc. succeeded in mass production of Reprosome, various customized exosomes induced from dermal fibroblasts using the Entr® automation system. UltraRepro®, recently developed by STEMON Inc., is the world's first equipment for automating Entr® core technology.

more

EXHIBIT

Plant Exosome and Plant collagen exosome

Stemon has isolated exosomes from broccoli, carrot, and dandelions by using Stemon's unique ultrasound technology, and supplies them as raw materials or ampoules. In addition, function-enhanced exosomes were developed by loading functional substances such as collagen, HA, PLLA, and PDLA in exosomes such as plant exosomes. These exosomes show cell-proliferative effects against human cells, so they can confirm the skin regeneration function.

More

PDRN exosome

PDRN exosome is a product containing low-molecular PDRN induced by STEMON’s original ultrasound technology in salmon and cod testis tissues. STEMON’s PDRN exosome has naturally a low molecular PDRN within the exosome through STEMON’s technology, so no impurities and DNA damage is caused by external stimuli. In addition, PDRN exosome can be absorbed to the skin at high rate through skin pores, so it can be used comfortably without pain caused by injecting existing PDRN products.

More

Reprosome® (Human iPS Exosome)

A cocktail of reprogramming factors (OCT4, SOX2, NANOG, and microRNAs) in the exosomes produced from induced pluripotent stem cells by Entr® technology. 1) Reprosome D raw material / D-27 ampoule for skin regeneration 2) Reprosome A raw material / A-27 Ampoule for Atopic Skin 3) Reprosome H raw material / H-27 ampoule for hair regeneration 4) Telomere Reprosome T raw material / T-27 ampoule

More

COMPANY INTRODUCTION

/STEMON Inc. is a specialized cell reprogramming popularization-leading company, opening up a new future using this game changer’s technology. Our mission is to chase a new health for good health and to be a leader in autologous cell therapy with Entr-based automation system. STEMON Inc. was established in March 2018, and based on our original technologies for cell reprogramming (Entr® technology) and mass production of exosome (Reprosome®) with selective specific factor (cell reprogramming factor) it has developed and produced extracellular vesicles-based therapeutics, medical devices, and dermal and hair care product. STEMON Inc. succeeded in mass production of Reprosome, various customized exosomes induced from dermal fibroblasts using the Entr® automation system. UltraRepro®, recently developed by STEMON Inc., is the world's first equipment for automating Entr® core technology.

QUICK LINK

Inquiry

Sender
/
Purpose *
Available Amount for a deal *
Details

SHARE

SHARE

REQUEST THE VIDEO MEETING

  • (KST, UTC+09:00)

    This above time is Korean local time.
    The time for meeting is based on Korean local time.
    Please check Korean time, and choose the time available.
Sender
/ BO SUNG ENG
Receiver
노시진 / STEMON Inc.
Purpose *
Available Amount for a deal *
Date *
Time *
Attendee 1 *
Attendee 2
Massage